Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Don’t sleep on Kansas City: How this Killa collab draws out KC’s ‘Little Villains’ at just the right season
Drafted from creativity in the Crossroads, a hand-sketched character inspired by Kansas City’s rising national profile (and the familiar personalities behind it) is now finding fans on and off the field … well, lawn. “The Killa” — a football player repping No. 87 — has made the leap from team yard decorations to a starring…
Disney preservationists launch $4M campaign, add key collaborators to save iconic animator’s KC studio
The legacy of Walt Disney’s foundational time in Kansas City — and the structure the famed animator left behind on Troost Avenue — must be preserved frame by frame, said supporters of an ambitious redevelopment project at the former Laugh-O-gram Studios. A newly launched “Dreams Start Here” campaign aims to secure a future for the historic…
His family-fried waffle spot is open for cheat day (but not breakfast); How Dennis Alazzeh played chicken with restaurant trends and won
Kansas City-battered Chick-In Waffle is expanding into Johnson County; its owner — a son from within Jerusalem Cafe’s founding family — gives the classic American chicken-and-waffle combo a global twist with flavors like Asian chili, tikka masala, and queso After slogging away in his father’s restaurants while in school, Dennis Alazzeh swore off the industry…
Theater’s $8.7M rehab set to bring Black Movie Hall of Fame, Black Rep to KC’s ‘cultural corridor’
A century after the storied structure’s construction, an $8.7 million redevelopment project at the Boone Theater in Kansas City’s historic 18th & Vine Jazz District aims to recapture the space’s potential as a cultural hub for the community — and a bridge to the city’s history. The long-awaited project at 1701 E. 18th St. is…